Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_019e8678b079c744df607292c03873b7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-547 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2006-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68a016b93914d2210e3480e352b3ad5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46087988092b38b0a3b917b1f54ac086 |
publicationDate |
2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009029974-A1 |
titleOfInvention |
Tumor Treatment with Gliotoxin Derivatives |
abstract |
The present invention describes the use of Notch2 inhibitors for producing a medicament for the treatment of tumours, which tumours are characterised by ligand-independent Notch2 fragments. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114641294-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021040389-A1 |
priorityDate |
2005-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |